Literature DB >> 25518008

Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants.

Venkatesh Sampath1, Jeffery S Garland2, Daniel Helbling1, David Dimmock1, Neil P Mulrooney3, Pippa M Simpson4, Jeffrey C Murray5, John M Dagle5.   

Abstract

BACKGROUND: Lung injury resulting from oxidative stress contributes to bronchopulmonary dysplasia (BPD) pathogenesis. Nuclear factor erythroid-2 related factor-2 (NFE2L2) regulates cytoprotective responses to oxidative stress by inducing enzymes containing antioxidant response elements (ARE). We hypothesized that ARE genetic variants will modulate susceptibility or severity of BPD in very-low-birth-weight (VLBW) infants.
METHODS: Blood samples obtained from VLBW infants were used for genotyping variants in the SOD2, NFE2L2, GCLC, GSTP1, HMOX1, and NQO1 genes. SNPs were genotyped utilizing TaqMan probes (Applied Biosystems (ABI), Grand Island, NY), and data were analyzed using the ABI HT7900. Genetic dominance and recessive models were tested to determine associations between SNPs and BPD.
RESULTS: In our cohort (n = 659), 284 infants had BPD; 135 of whom developed severe BPD. Presence of the hypomorphic NQO1 SNP (rs1800566) in a homozygous state was associated with increased BPD, while presence of the NFE2L2 SNP (rs6721961) was associated with decreased severe BPD in the entire cohort and in Caucasian infants. In regression models that adjusted for epidemiological confounders, the NQO1 and the NFE2L2 SNPs were associated with BPD and severe BPD, respectively.
CONCLUSION: Genetic variants in NFE2L2-ARE axis may contribute to the variance in liability to BPD observed in preterm infants. These results require confirmation in independent cohorts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25518008      PMCID: PMC4522928          DOI: 10.1038/pr.2014.200

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  40 in total

1.  Familial and genetic susceptibility to major neonatal morbidities in preterm twins.

Authors:  Vineet Bhandari; Matthew J Bizzarro; Anupama Shetty; Xiaoyun Zhong; Grier P Page; Heping Zhang; Laura R Ment; Jeffrey R Gruen
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

Review 2.  Genetic mechanisms of susceptibility to oxidative lung injury in mice.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Free Radic Biol Med       Date:  2006-11-23       Impact factor: 7.376

3.  The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability.

Authors:  Angela Sutton; Audrey Imbert; Anissa Igoudjil; Véronique Descatoire; Sophie Cazanave; Dominique Pessayre; Françoise Degoul
Journal:  Pharmacogenet Genomics       Date:  2005-05       Impact factor: 2.089

4.  Oxygen delivery through nasal cannulae to preterm infants: can practice be improved?

Authors:  Michele Walsh; William Engle; Abbot Laptook; S Nadya J Kazzi; Susie Buchter; Maynard Rasmussen; Qing Yao
Journal:  Pediatrics       Date:  2005-10       Impact factor: 7.124

5.  Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury.

Authors:  Jacqui M Marzec; Jason D Christie; Sekhar P Reddy; Anne E Jedlicka; Hue Vuong; Paul N Lanken; Richard Aplenc; Tae Yamamoto; Masayuki Yamamoto; Hye-Youn Cho; Steven R Kleeberger
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

6.  Expression and developmental profile of antioxidant enzymes in human lung and liver.

Authors:  T M Asikainen; K O Raivio; M Saksela; V L Kinnula
Journal:  Am J Respir Cell Mol Biol       Date:  1998-12       Impact factor: 6.914

Review 7.  Nrf2 defends the lung from oxidative stress.

Authors:  Hye-Youn Cho; Sekhar P Reddy; Steven R Kleeberger
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

8.  Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties.

Authors:  P Zimniak; B Nanduri; S Pikuła; J Bandorowicz-Pikuła; S S Singhal; S K Srivastava; S Awasthi; Y C Awasthi
Journal:  Eur J Biochem       Date:  1994-09-15

Review 9.  Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy.

Authors:  Tiina M Asikainen; Carl W White
Journal:  Antioxid Redox Signal       Date:  2004-02       Impact factor: 8.401

Review 10.  NQO1, MPO, and the risk of lung cancer: a HuGE review.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu; Koichi Takayama; Yoichi Nakanishi
Journal:  Genet Med       Date:  2005-09       Impact factor: 8.822

View more
  18 in total

1.  β-Naphthoflavone treatment attenuates neonatal hyperoxic lung injury in wild type and Cyp1a2-knockout mice.

Authors:  Krithika Lingappan; Paramahamsa Maturu; Yanhong Wei Liang; Weiwu Jiang; Lihua Wang; Bhagavatula Moorthy; Xanthi I Couroucli
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-26       Impact factor: 4.219

Review 2.  Genetic predisposition to bronchopulmonary dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Semin Perinatol       Date:  2015-10-23       Impact factor: 3.300

3.  Vascular Endothelial Mitochondrial Function Predicts Death or Pulmonary Outcomes in Preterm Infants.

Authors:  Jegen Kandasamy; Nelida Olave; Scott W Ballinger; Namasivayam Ambalavanan
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

4.  Necrotizing Enterocolitis Is Not Associated With Sequence Variants in Antioxidant Response Genes in Premature Infants.

Authors:  Venkatesh Sampath; Daniel Helbling; Heather Menden; David Dimmock; Neil P Mulrooney; Jeffrey C Murray; John M Dagle; Jeffery S Garland
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-03       Impact factor: 2.839

5.  Potential therapeutic targets in Nrf2-dependent protection against neonatal respiratory distress disease predicted by cDNA microarray analysis and bioinformatics tools.

Authors:  Hye-Youn Cho; Xuting Wang; Jianying Li; Douglas A Bell; Steven R Kleeberger
Journal:  Curr Opin Toxicol       Date:  2016-10-29

Review 6.  Functional polymorphisms in Nrf2: implications for human disease.

Authors:  Hye-Youn Cho; Jacqui Marzec; Steven R Kleeberger
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

Review 7.  Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Arch Toxicol       Date:  2015-07-21       Impact factor: 5.153

8.  Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.

Authors:  T F Spracklen; A A Vorster; L Ramma; S Dalvie; R S Ramesar
Journal:  Pharmacogenomics J       Date:  2016-07-26       Impact factor: 3.550

9.  Newborn Mice Lacking the Gene for Cyp1a1 Are More Susceptible to Oxygen-Mediated Lung Injury, and Are Rescued by Postnatal β-Naphthoflavone Administration: Implications for Bronchopulmonary Dysplasia in Premature Infants.

Authors:  Paramahamsa Maturu; Yanhong Wei-Liang; Weiwu Jiang; Lihua Wang; Krithika Lingappan; Roberto Barrios; Yao Liang; Bhagavatula Moorthy; Xanthi I Couroucli
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

10.  Association between oxidative DNA damage and the expression of 8-oxoguanine DNA glycosylase 1 in lung epithelial cells of neonatal rats exposed to hyperoxia.

Authors:  Linlin Jin; Haiping Yang; Jianhua Fu; Xindong Xue; Li Yao; Lin Qiao
Journal:  Mol Med Rep       Date:  2015-02-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.